Page last updated: 2024-10-21

sch-48973 and Poliomyelitis

sch-48973 has been researched along with Poliomyelitis in 4 studies

Poliomyelitis: An acute infectious disease of humans, particularly children, caused by any of three serotypes of human poliovirus (POLIOVIRUS). Usually the infection is limited to the gastrointestinal tract and nasopharynx, and is often asymptomatic. The central nervous system, primarily the spinal cord, may be affected, leading to rapidly progressive paralysis, coarse FASCICULATION and hyporeflexia. Motor neurons are primarily affected. Encephalitis may also occur. The virus replicates in the nervous system, and may cause significant neuronal loss, most notably in the spinal cord. A rare related condition, nonpoliovirus poliomyelitis, may result from infections with nonpoliovirus enteroviruses. (From Adams et al., Principles of Neurology, 6th ed, pp764-5)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (25.00)18.2507
2000's0 (0.00)29.6817
2010's2 (50.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Copelyn, J1
Hincks, JR2
Wilmshurst, JM1
Petersen, W1
Howard, W1
Jallow, S1
Moonsamy, S1
Seakamela, L1
Suchard, M1
Collett, MS2
Eley, B1
Sutter, RW1
Modlin, JF2
Zaffran, M1
Benschop, K1
Duizer, E1
van der Avoort, H1
Rhoden, E1
Liu, H1
Oberste, MS1
McKinlay, MA1
Hartford, M1
Buontempo, PJ1
Cox, S1
Wright-Minogue, J1
DeMartino, JL1
Skelton, AM1
Ferrari, E1
Albin, R1
Rozhon, EJ1
Girijavallabhan, V1
O'Connell, JF1

Trials

1 trial available for sch-48973 and Poliomyelitis

ArticleYear
Antiviral Activity of Pocapavir in a Randomized, Blinded, Placebo-Controlled Human Oral Poliovirus Vaccine Challenge Model.
    The Journal of infectious diseases, 2017, Feb-01, Volume: 215, Issue:3

    Topics: Adult; Antiviral Agents; Cohort Studies; Female; Humans; Male; Middle Aged; Phenyl Ethers; Poliomyel

2017

Other Studies

3 other studies available for sch-48973 and Poliomyelitis

ArticleYear
Clearance of Immunodeficiency-associated Vaccine-derived Poliovirus Infection With Pocapavir.
    The Pediatric infectious disease journal, 2020, Volume: 39, Issue:5

    Topics: Agammaglobulinemia; Antiviral Agents; Drugs, Investigational; Feces; Genetic Diseases, X-Linked; Hum

2020
Completing Polio Eradication: The Case for Antiviral Drugs.
    The Journal of infectious diseases, 2017, 02-01, Volume: 215, Issue:3

    Topics: Antiviral Agents; Humans; Phenyl Ethers; Poliomyelitis; Poliovirus Vaccine, Oral

2017
SCH 48973: a potent, broad-spectrum, antienterovirus compound.
    Antimicrobial agents and chemotherapy, 1997, Volume: 41, Issue:6

    Topics: Animals; Antiviral Agents; Brain; Enterovirus; Enterovirus Infections; Halogenated Diphenyl Ethers;

1997